Karyopharm Therapeutics Inc. is a leading commercial-stage pharmaceutical company committed to developing innovative cancer therapies. Driven by a deep respect for patients facing cancer, Karyopharm focuses on improving lives and defeating cancer through pioneering research and development.
As leaders in XPO1 inhibition, Karyopharm Therapeutics Inc. is dedicated to creating a targeted pipeline addressing significant unmet needs in cancer treatment. Their focus areas include multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
Located at 85 Wells Avenue, Newton, MA 02459, US, Karyopharm Therapeutics Inc. is poised for continued growth and commercial success. We invite the management team at Karyopharm to enhance your company's visibility by creating a customized and exclusive company showcase and product listing on our platform.
Karyopharm Therapeutics Inc. est une société pharmaceutique commerciale de premier plan engagée dans le développement de thérapies innovantes contre le cancer. Animé par un profond respect pour les patients atteints de cancer, Karyopharm se concentre sur l'amélioration de la vie et la lutte contre le cancer grâce à la recherche et au développement de pointe.
En tant que leader de l'inhibition du XPO1, Karyopharm Therapeutics Inc. se consacre à la création d'un pipeline ciblé répondant aux besoins importants non satisfaits en matière de traitement du cancer. Leurs domaines d'intervention comprennent le myélome multiple, le cancer de l'endomètre, la myélofibrose et le lymphome diffus à grandes cellules B (LDGCB).
Situé au 85 Wells Avenue, Newton, MA 02459, États-Unis, Karyopharm Therapeutics Inc. est prêt pour une croissance continue et un succès commercial. Nous invitons l'équipe de direction de Karyopharm à accroître la visibilité de votre entreprise en créant une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme.
Compare Karyopharm Therapeutics Inc. with 3 companies in Pharmaceutical-Manufacturing
| Comparison Field |
Karyopharm Therapeutics I...Main Company |
Royal United Hospita...View Profile |
adMare BioInnovation...View Profile |
AirEmailView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1992 | 2019 | 2020 |
|
Company Size
|
— | 5,001-10,000 | 51-200 | 2-10 |
|
City
|
Newton, MA | Bath, Somerset | ||
|
Country
|
United States | United Kingdom | ||
|
Skills & Keywords
Comparing with main company
|
19 Total Skills
Pharmaceutical Manufacturing
Cancer Therapies
XPO1 Inhibition
Multiple Myeloma
Endometrial Cancer
Myelofibrosis
DLBCL
oncology
drugdiscovery
pharmaceutical
biotech
solidtumors
medical
lymphoma
multiplemyeloma
clinicaltrials
research
clinicalresearch
healthcare
|
20 Total
20 Unique
Unique Skills:
cardiology
ear
elective surgery
endocrinology & diabetes
gastroenterology
geriatric medicine
+14
|
14 Total
14 Unique
Unique Skills:
biologie
biotechnology
drug development
drug discovery
health
life sciences
+8
|
17 Total
17 Unique
Unique Skills:
clinical trial
comfort breaks
communication
email
email tenant
hyperlinks
+11
|
Other organizations in the same industry
This company is also known as